Concepedia

Viktor Blazhko

VB

Statistics

Publications

3

Citations

788

H-Index

3

Active since

2012

Affiliations

Kharkiv Regional Clinical Psychiatric Hospital No 3(Current)

Viktor Blazhko is an author at Kharkiv Regional Clinical Psychiatric Hospital No 3 specializing in pharmacotherapy, pharmacology, and clinical pharmacology.

Publications per year

2012–2018

3

Publications

3

Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial

Jørgen Vestbo, Alberto Papi, Massimo Corradi et al. · The Lancet · 2017 · 442 citations · Full text

, , +17

Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

William W. Busse, Eugene R. Bleecker, J Mark FitzGerald et al. · The Lancet Respiratory Medicine · 2018 · 311 citations

, , +6

Safety and efficacy of fluticasone/formoterol combination therapy in adolescent and adult patients with mild-to-moderate asthma: a randomised controlled trial

Robert A. Nathan, Anthony D’Urzo, Viktor Blazhko et al. · BMC Pulmonary Medicine · 2012 · 35 citations · Full text

, , +17

1–3 of 3